Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Slamon Dennis, Director. Officer active across 1 company, notably Biomarin Pharmaceutical INC. In total, 5 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €407k. History available since 25 May 2021. The latest transaction was disclosed on 18 March 2024 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Slamon Dennis is a Board Member at BIOMARIN PHARMACEUTICAL INC. He contributes to the strategic direction of the company and oversees its operations, bringing his experience in the pharmaceutical sector.